euglycemic

(redirected from euglycaemic)

eu·gly·ce·mic

(yū'glī-sē'mik),
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic

eu·gly·ce·mic

(yū'glī-sē'mik)
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic, euglycaemic.
References in periodicals archive ?
Insulin resistant individuals maintain euglycaemic status at the expense of pancreatic oversecretion as indicated by the high insulin values.
Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus.
1-3 All these factors are as important in women who live with diabetes as they are in euglycaemic women.
Although, many women with GDM mount substantial insulin response, this compensatory increase is unable to effectively reduce fasting or postprandial glucose to euglycaemic concentrations.
WHO clinical criteria for metabolic syndrome * Insulin resistance, identified by one of the following: * Type 2 diabetes * Impaired fasting glucose * Impaired glucose tolerance * Or, for those with normal fasting glucose levels (<110 mg/dL), glucose uptake below the lowest quartile for background population under investigation under hyperinsulinaemic, euglycaemic conditions Plus any two of the following: * Antihypertensive medication and/or high blood pressure ([greater than or equal to] 140 mmHg systolic or [greater than or equal to] 90 mmHg diastolic) * Plasma triglycerides [greater than or equal to] 150 mg/dL ([greater than or equal to] 1.
An insulinresistant hypertriglyceridaemic normotensive obese dog model: assessment of insulin resistance by the euglycaemic hyperinsulinaemic clamp in combination with the stable isotope technique," Journal ofAnimal Physiology and Animal Nutrition, vol.
Insulin sensitivity was also assessed using homoeostasis model assessment (HOMA) indices and the euglycaemic hyperinsulinaemic clamp technique.
The gold standard for determining insulin resistance is the hyperinsulinaemic euglycaemic clamp study.
It was reported that two nights of CPAP treatment improved insulin sensitivity as assessed by the hyperinsulinaemic euglycaemic clamp in a group of non-diabetic men with moderate OSA, and the effect was more prominent in non obese patients with a BMI <30 kg/[m.
Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.
The impact of tenofovir on insulin sensitivity and lipids has been studied in healthy male volunteers by using hyperinsulinaemic euglycaemic clamping [16].